Evidence map›Paper›PMID 40122582›Full record

Observational studyLupus science & medicine2025

Using patient-reported measures to predict hospitalisation in a population-based lupus cohort.

Sung Sam Lim, Sandra Sze-Jung Wu, Ryan Ross, Gaobin Bao, Megan Richards, Liisa Palmer, Gary Bryant

Abstract readObservational Study
In one paragraph

Observational study in Lupus science & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sung Sam LimDepartment of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA sslim@emory.edu.ORCID 0000-0003-2361-0787
Sandra Sze-Jung WuRespiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, Delaware, USA.
Ryan RossMerative LP, Ann Arbor, Michigan, USA.
Gaobin BaoDepartment of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA.
Megan RichardsMerative LP, Ann Arbor, Michigan, USA.ORCID 0000-0003-0737-389X
Liisa PalmerMerative LP, Ann Arbor, Michigan, USA.
Gary BryantRespiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Wilmington, Delaware, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSLE is a multisystem autoimmune disease where periods of disease activity, often difficult to predict, can cause irreversible disease damage. This study aimed to develop a patient-centric predictive model using real-world data that can identify patients with SLE at a higher risk of hospitalisation compared with the general SLE population.

methodsThis observational, retrospective analysis used data from the Georgians Organized Against Lupus (GOAL) cohort from 2011 to 2013. The GOAL cohort is a population-based SLE cohort that collects yearly self-report surveys covering participants' sociodemographic characteristics, clinical characteristics and perceived SLE symptoms (using the Systemic Lupus Activity Questionnaire (SLAQ)). GOAL data were linked to the Georgia Hospital Discharge Database to collect participants' all-cause hospitalisation events in the 6 months following survey completion. A two-step approach was used to predict all-cause hospitalisations-logistic regressions selected a list of GOAL predictors that were subsequently included in the classification and regression tree (CART) models to generate patient subsets based on estimated hospitalisation rates.

resultsThere were 846 participants who completed 1486 surveys. Participants who were hospitalised within 6 months after survey completion were more likely to be younger, living in poverty and have more reported SLE symptoms than participants without a hospitalisation. CART modelling identified participants who reported any weight loss without trying, severe fatigue and Raynaud's symptoms as most likely to have an all-cause hospitalisation: one in three (34%) patients in this subset were hospitalised in the 6 months following survey completion, 2.6-fold the hospitalisation rates of the overall GOAL cohort (13%) and 6.8-fold the rate in the subset with the lowest hospitalisation rate (5%).

conclusionsThis study suggests that patient-reported SLE symptoms and disease activity, specifically certain components of the SLAQ, may be of value in SLE risk management when considering hospitalisation reduction as a treatment goal.

Indexed as

HospitalizationLupus Erythematosus, SystemicPatient Reported Outcome MeasuresAdultFemaleGeorgiaHumansMaleMiddle AgedRetrospective StudiesSelf ReportSeverity of Illness IndexSurveys and QuestionnairesYoung AdultOutcome Assessment, Health CareRisk FactorsSystemic Lupus Erythematosus

Identifiers

PMID40122582
PMCPMC11931938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.